Germany

News

Alzheimer's drug Leqembi launched in first EU markets

Germany and Austria are the first countries in the EU to see the launch of Leqembi, Eisai and Biogen's much-delayed treatment for Alzheimer's.

News

Santhera's DMD drug poised for wider rollout in Germany

Santhera has agreed pricing and reimbursement for its Duchenne muscular dystrophy drug Agamree with German health funds representing 90% of patients.

News

Official opening of Co.Lab Berlin site, ribbon cutting

Bayer opens Berlin incubator and welcomes first resident

Bayer's network of Co.Lab life sciences incubators has expanded once again with the official opening of a site in Berlin, its first in Europe

News

LEO launches chronic hand eczema drug in its first market

Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE).

News

Germany inches closer to confidential pricing for drugs

Pharma companies who want to keep the prices of their medicines private in Germany may soon be able to do so – as long as they meet certain conditions.

News

Mahana’s DTx for IBS gets permanent reimbursement in Germany

Mahana Therapeutics has been granted permanent reimbursement in Germany for its Cara Care for irritable bowel syndrome (IBS), paving the way for greater patient access to the digital therap

Alzheimer's drug Leqembi launched in first EU markets

Santhera's DMD drug poised for wider rollout in Germany

Bayer opens Berlin incubator and welcomes first resident

LEO launches chronic hand eczema drug in its first market

Germany inches closer to confidential pricing for drugs

Mahana’s DTx for IBS gets permanent reimbursement in Germany

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Germany

Editor's Picks